EXPAREL is a bupivacaine liposome injectable suspension for post surgical pain.
Pacira also reported an average of 28 new accounts ordering EXPAREL, totaling at 363 for the second quarter of 2014. 2,815 accounts have ordered EXPAREL through June 30, with 469 accounts ordering more than $100,000 worth of product since the launch.
More articles on Pacira:
4 Latest Drug Approvals
Study: EXPAREL Infiltration Effectively Controls Postsurgical Pain
Pacira Joins NPSF Coalition
